Literature DB >> 596948

Polymyalgia rheumatica. Assessment of disease activity using erythrocyte sedimentation rate and plasma viscosity.

W Esselinckx, R C Bucknall, A S Dixon.   

Abstract

Comparison of clinically assessed activity of disease with 112 paired readings of the erythrocyte sedimentation rate (ESR) and the plasma viscosity (PV) in 23 patients with polymyalgia rheumatica (PMR) showed the following. (1) A correlation between ESR and PV in both sexes, reaching the significance obtained in a comparison group of patients with rheumatoid arthritis (RA) (109 paired readings), with no significant difference between the PMR and RA groups on analysis of variance of the regression slopes. (2) A degree of scatter of readings around the regression lines so that they could not be used for prediction of ESR from the PV or vice versa. (3) varkappa(2) analysis of normal and abnormal values of ESR and PV which showed a highly significant correlation. However 10 readings were abnormally high for ESR in the presence of a normal PV. 5 of these 10 observations were associated with clinical features of disease activity. 20 readings were abnormally high for PV in spite of a normal ESR with only one instance of clinical activity. These data indicate that it is not possible to provide exact guidelines for a ;safe' level of ESR or PV applicable to the individual patient, and measurement of both these indices of disease activity is recommended.

Entities:  

Mesh:

Year:  1977        PMID: 596948      PMCID: PMC1000163          DOI: 10.1136/ard.36.6.560

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  13 in total

1.  PLASMA VISCOSITY IN CLINICAL LABORATORY PRACTICE.

Authors:  R D EASTHAM; E H MORGAN
Journal:  J Med Lab Technol       Date:  1965-04

2.  Giant-cell arteritis, or arteritis of the aged.

Authors:  J W PAULLEY; J P HUGHES
Journal:  Br Med J       Date:  1960-11-26

3.  [The syndrome of temporal arteritis].

Authors:  J L ROUX
Journal:  Helv Med Acta Suppl       Date:  1954

4.  Early symptoms of temporal arteritis.

Authors:  M J Harrison; A T Bevan
Journal:  Lancet       Date:  1967-09-23       Impact factor: 79.321

5.  Therapeutic hazards of phenylbutazone and oxyphenbutazone in polymyalgia rheumatica.

Authors:  B Wadman; I Werner
Journal:  Lancet       Date:  1967-03-18       Impact factor: 79.321

6.  Polymyalgia rheumatica -- a clinical study with particular reference to arterial disease.

Authors:  A G Mowat; B L Hazleman
Journal:  J Rheumatol       Date:  1974-06       Impact factor: 4.666

7.  Relationship of the erythrocyte sedimentation rate to viscosity and plasma proteins in rheumatoid arthritis.

Authors:  R A Crockson; A P Crockson
Journal:  Ann Rheum Dis       Date:  1974-01       Impact factor: 19.103

Review 8.  The viscosity of human blood plasma; its measurement in health and disease.

Authors:  J Harkness
Journal:  Biorheology       Date:  1971-12       Impact factor: 1.875

9.  Polymyalgia rheumatica. Abrupt and gradual withdrawal of prednisolone treatment, clinical and laboratory observations.

Authors:  W Esselinckx; S M Doherty; A S Dixon
Journal:  Ann Rheum Dis       Date:  1977-06       Impact factor: 19.103

10.  Development of giant cell (temporal) arteritis in a patient 'adequately' treated for polymyalgia rheumatica.

Authors:  R I Rynes; P Mika; L E Bartholomew
Journal:  Ann Rheum Dis       Date:  1977-02       Impact factor: 19.103

View more
  1 in total

1.  Plasma viscosity in giant cell arteritis as a predictor of disease activity.

Authors:  M Gudmundsson; E Nordborg; B A Bengtsson; A Bjelle
Journal:  Ann Rheum Dis       Date:  1993-02       Impact factor: 19.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.